79.45

0.26% -0.21

After Hours: 79.56 0.11 +0.14%

Praxis Precision Medicines Inc (PRAX)

Overview News Price History Option Chain Financials Discussions Forecast

Praxis Precision Medicines Inc stock is traded at $79.45, with a volume of 174.68K. It is down -0.26% in the last 24 hours and up +11.06% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Previous Close:

$79.66

Open:

$79.93

24h Volume:

174.68K

Relative Volume:

0.57

Market Cap:

$1.49B

Revenue:

$1.77M

Net Income/Loss:

$-123.74M

P/E Ratio:

-26.22

EPS:

-3.03

Net Cash Flow:

$-95.21M

1W Performance:

+7.83%

1M Performance:

+11.06%

6M Performance:

+80.24%

1Y Performance:

+6,466%

1-Day Range:

$77.47

$81.09

1-Week Range:

$71.27

$81.09

52-Week Range:

$1.07

$86.93

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name

Praxis Precision Medicines Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

617-300-8460

Address

99 HIGH STREET, 30TH FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

PRAX's Discussions on Twitter

Compare PRAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRAX Praxis Precision Medicines Inc	79.45	1.49B	1.77M	-123.74M	-95.21M	-3.03
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-05-24	Initiated	Oppenheimer	Outperform
Jun-24-24	Initiated	Needham	Buy
Jun-18-24	Initiated	Guggenheim	Buy
May-01-24	Initiated	Robert W. Baird	Outperform
Sep-19-23	Initiated	Truist	Buy
Jun-06-22	Downgrade	Wedbush	Outperform → Neutral
Dec-16-21	Initiated	H.C. Wainwright	Buy
Aug-26-21	Initiated	BofA Securities	Buy
Apr-26-21	Initiated	William Blair	Outperform
Nov-11-20	Initiated	Wedbush	Outperform
Nov-10-20	Initiated	Cowen	Outperform
Nov-10-20	Initiated	Evercore ISI	Outperform
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

Nov 27, 2024

Long Term Trading Analysis for (PRAX) - Stock Traders Daily

Nov 27, 2024

Nov 26, 2024

Praxis Precision Medicines to Showcase Updates from Largest - GlobeNewswire

Nov 26, 2024

Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting - The Manila Times

Nov 26, 2024

Praxis to Present Breakthrough Epilepsy Drug Data at Major 2024 Conference | PRAX Stock News - StockTitan

Nov 26, 2024

Nov 20, 2024

Why Praxis Precision Medicines Stock Is Trading Higher Tuesday - MSN

Nov 20, 2024

Nov 18, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down After Insider Selling - MarketBeat

Nov 18, 2024

Nov 17, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by CIBC Asset Management Inc - MarketBeat

Nov 17, 2024

Nov 16, 2024

Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat

Nov 16, 2024

Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat

Nov 16, 2024

(PRAX) Proactive Strategies - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com India

Nov 15, 2024

Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia

Nov 15, 2024

Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com

Nov 15, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat

Nov 15, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 15, 2024

Nov 14, 2024

Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com

Nov 14, 2024

Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com

Nov 13, 2024

Nov 11, 2024

Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat

Nov 11, 2024

FY2024 Earnings Estimate for PRAX Issued By HC Wainwright - MarketBeat

Nov 11, 2024

Nov 08, 2024

Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024

Nov 07, 2024

HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat

Nov 07, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024